Ákos Nagy

9PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer geneticsLiquid biopsiesMedical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 21, 2023
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Tamás László, Lili Kotmayer, Viktória Fésüs

|Sep 28, 2023
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.

Andras Jozsef Barna, Zoltan Herold, Miklos Acs

|Aug 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma.

Franziska Briest, Daniel Noerenberg, Cornelius Hennch

|Jun 01, 2023
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Ákos Nagy, Bence Bátai, Laura Kiss

|May 26, 2023
Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

Anita Marx, Magdolna Osváth, Bence Szikora

|Apr 03, 2023
TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin.

Szintia Almási, Levente Kuthi, Anita Sejben

Pageof 2

Frequent Collaborators

2 joint publications

Zoltan Herold

2 joint publications

Attila Marcell Szasz

2 joint publications

Csaba Bödör

1 joint publications

Donát Alpár